Hot Pursuit     04-Nov-24
Sun Pharma tumbles after US court halts Leqselvi launch
Sun Pharmaceutical Industries slipped 4.30% to 1,778.85 after the US District Court of New Jersey has decided to grant a preliminary injunction delaying the launch of Leqselvi (Baldness treatment) in the US.
Aa result of the court's decision, Sun Pharma has been temporarily barred from launching Leqselvi until a subsequent favorable court decision or until the expiry of patent in lawsuit, whichever is earlier, it added.

Earlier on 1 August 2024, the pharma major had informed that it filed a motion seeking a preliminary injunction in a US court to prevent the launch of LEQSELVI.

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with specialty and generic presence and India's top pharma company.

The company’s consolidated net profit jumped 27.97% to Rs 3,040.16 crore on 9.01% rise in revenue from operations to Rs 13,291.39 crore in Q2 FY25 over Q2 FY24.

Previous News
  Sun Pharmaceuticals Industries EGM scheduled
 ( Corporate News - 11-Dec-24   13:58 )
  Market at day's high; European mrkt decline
 ( Market Commentary - Mid-Session 29-Nov-24   13:32 )
  Nifty tanks below 23,900; media shares slide; VIX jumps 7.21%
 ( Market Commentary - Mid-Session 04-Nov-24   12:32 )
  Sun Pharma tumbles after US court halts Leqselvi launch
 ( Hot Pursuit - 04-Nov-24   11:14 )
  Sun Pharmaceuticals Industries
 ( Results - Analysis 29-Oct-24   10:23 )
  Sun Pharmaceuticals Industries consolidated net profit rises 27.98% in the September 2024 quarter
 ( Results - Announcements 28-Oct-24   16:57 )
  Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr
 ( Hot Pursuit - 28-Oct-24   16:01 )
  Sun Pharmaceuticals Industries Ltd up for third straight session
 ( Hot Pursuit - 28-Oct-24   13:05 )
  Sun Pharmaceuticals Industries to hold board meeting
 ( Corporate News - 09-Oct-24   17:30 )
  Sun Pharma inks global licensing agreement with Philogen
 ( Corporate News - 01-Oct-24   10:34 )
  Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun
 ( Hot Pursuit - 01-Oct-24   10:34 )
Other Stories
  Shakti Pumps hits the roof after bagging order worth Rs 754-cr from MSEDC
  11-Dec-24   15:46
  Swiggy dips post lock-in period expiry
  11-Dec-24   15:28
  ITI Ltd leads losers in 'A' group
  11-Dec-24   15:00
  Blue Cloud Softech Solutions Ltd leads losers in 'B' group
  11-Dec-24   14:45
  Dee Development Engineers rises on bagging $16.5-million order
  11-Dec-24   14:41
  Volumes soar at Jupiter Wagons Ltd counter
  11-Dec-24   14:30
  JSW Steel gets Rs 64-cr show cause notice from GST Authority
  11-Dec-24   14:23
  Utilties stocks edge lower
  11-Dec-24   14:00
  Power stocks slide
  11-Dec-24   14:00
  Banking shares fall
  11-Dec-24   14:00
Back Top